Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Alx Oncology Holdings Inc shares valued at $633 were sold by Pinto Shelly on Feb 19 ’25. At $1.15 per share, Pinto Shelly sold 550 shares. The insider’s holdings dropped to 87,352 shares worth approximately $42802.479999999996 following the completion of this transaction.
Also, Pons Jaume sold 1,326 shares, netting a total of over 1,525 in proceeds. Following the sale of shares at $1.15 each, the insider now holds 579,388 shares.
Before that, Lettmann Jason had sold 2,159 shares from its account. In a trade valued at $2,483, the CHIEF EXECUTIVE OFFICER traded Alx Oncology Holdings Inc shares for $1.15 each. Upon closing the transaction, the insider’s holdings decreased to 2,159 shares, worth approximately $83432.3.
As published in a research note from Jefferies on March 06, 2025, Alx Oncology Holdings Inc [ALXO] has been rated up from a Hold to a Buy and the price target has been revised to $3 from $2. Analysts at Jefferies downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in mid December. As of March 08, 2024, Stifel has decreased its “Buy” rating to a “Hold” for ALXO. Earlier on December 08, 2023, Jefferies upgraded its rating. Their new recommendation was “a Buy” for ALXO stock which previously was a “a Hold”.
Analyzing ALXO Stock Performance
On last trading session,, Alx Oncology Holdings Inc [NASDAQ: ALXO] plunged -1.78% to $0.49. The stock’s lowest price that day was $0.4813, but it reached a high of $0.5005 in the same session. During the last five days, there has been a drop of approximately -11.30%. Over the course of the year, Alx Oncology Holdings Inc shares have dropped approximately -70.87%. Shares of the company reached a 52-week high of $1.9400 on 01/08/25 and a 52-week low of $0.4051 on 05/21/25.
Support And Resistance Levels for Alx Oncology Holdings Inc (ALXO)
According to the 24-hour chart, there is a support level at 0.4784, which, if violated, would cause prices to drop to 0.4702. In the upper region, resistance lies at 0.4976. The next price resistance is at 0.5086. RSI (Relative Strength Index) is 44.99 on the 14-day chart, showing neutral technical sentiment.
Is Alx Oncology Holdings Inc subject to short interest?
Stocks of Alx Oncology Holdings Inc saw a sharp steep in short interest on 2025-05-30 dropping by -0.36 million shares to 5.69 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 6.05 million shares. A decline of -6.29% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 12.83 of the overall float, the days-to-cover ratio (short ratio) decline to 12.83.
Which companies own the most shares of Alx Oncology Holdings Inc (ALXO)?
In terms of Alx Oncology Holdings Inc share price expectations, FactSet research, analysts set an average price target of 1.5 in the next 12 months, up nearly 200.0% from the previous closing price of $0.50. Analysts anticipate Alx Oncology Holdings Inc stock to reach 1.5 by 2025, with the lowest price target being 1.5. In spite of this, 5 analysts ranked Alx Oncology Holdings Inc stock as Buy at the end of 2025. On December 22, 2021, Jefferies assigned a price target of “a Hold” to the stock and downgraded coverage with a $25.
